Ambient Scribes
S

Speke

Speke is the ambient AI scribe from ScribeAmerica, the largest human medical scribe company in the United States, serving over 1,000 clients across more than 3,000 sites and around 30 million encounters a year. That heritage produces the most distinctive architecture in this category: Speke does not replace the human scribe, it fuses with one. Ambient capture generates the note, and ScribeAmerica scribes review and edit it for accuracy and completeness, alerting the provider through the app when information is missing. The amount of human review is a purchasable variable across three tiers, Speke Express, Speke Plus and Speke Pro, so a buyer chooses how much oversight to fund rather than accepting whatever the vendor built. It covers around 80 specialties across ambulatory, acute and urgent care with bidirectional EHR integration, and it carries a KLAS Emerging Technology Spotlight. It is also the only scribe assessed here that tells buyers plainly it cannot act as an interpreter and that a native speaker must corroborate notes generated from non English conversation.

Last VerifiedJuly 23, 2026
Compare Speke with other vendors
Founded
Headquarters
Fort Lauderdale, Florida, United States
Categories
ambient-scribes
Assessment

Capability Axes

AI Capability
AI Centrality
B
Vendor Published

The model does real work, but the vendor's own pitch is that the model is not sufficient on its own. Speke is explicitly positioned as AI paired with ScribeAmerica scribes, and the parent's moat is a twenty year staffing and scribe services business spanning 3,000 sites, not a model. This is not the services rejection this index applied to CORL or symplr, because Speke is a software product with a services layer rather than a services business wearing AI language, and the index already accommodates tiered human review through Commure. Graded B: the intelligence is genuine and central, but so is the human workforce, and the vendor says so rather than hiding it.

Autonomy and Oversight Model
A
Vendor Published

The strongest oversight architecture in this category, and it earns the grade structurally rather than by promise. Trained medical scribes review and edit generated notes for accuracy and completeness before the provider signs, and they actively alert the provider through the app when the encounter is missing information a note requires, which is a prompt no automated scribe produces because no automated scribe knows what it failed to hear. Crucially the depth of that review is a purchasable variable across Express, Plus and Pro tiers, so oversight is a procurement decision the buyer controls rather than a fixed vendor design. Compare Abridge, graded A for Linked Evidence, which makes verification auditable; Speke makes it someone's job. Held short of a published edit rate or acceptance threshold, which would be the obvious next disclosure.

Model and Technology Transparency
C
Vendor Published

No accuracy figure, no model card, no named models and no evaluation methodology. The technical claims offered are credentials rather than disclosures, notably that product and machine learning staff were hired from Amazon and Microsoft, which says nothing about how the system performs. Language coverage is also stated inconsistently across the vendor's own properties, appearing as 25 or more languages in one place and 30 or more in another.

Clinical and Operational Evidence
B
Third Party Estimated

Independent third party validation exists, which lifts this above the vendor reported claims typical of the category, but it should be read for what it is. KLAS published an Emerging Technology Spotlight on Speke, which validates the experiences of organisations actually using it rather than repeating vendor assertions. An Emerging Technology Spotlight is an early stage validation based on a small interview base and is not equivalent to a Best in KLAS ranking, so it evidences real buyer experience rather than comparative performance. Vendor reported figures alongside it, up to 50 percent less documentation time and an average of 2.5 hours saved daily, carry no denominator or design. No peer reviewed publication located.

AI Safety and PHI Stewardship
C
Vendor Published

The mechanism that earns this product its autonomy A creates its distinctive privacy exposure, and buyers should evaluate both as one decision rather than separately. Human scribes reviewing and editing notes means recorded clinical conversation and draft documentation are read by a human workforce, which is a materially larger and more variable PHI exposure surface than a fully automated pipeline. Nothing was located on where that workforce sits, how it is vetted, whether review is performed onshore, how audio and transcripts are retained, or whether customer data trains models. Given that ScribeAmerica also operates a TeleScribe service, the workforce location question is the specific thing to get answered in writing.

Regulatory and Compliance
HIPAA and BAA Posture
Not rated

Not assessed. No product specific business associate agreement posture was located in this pass, which matters more than usual given a human review workforce handling PHI.

Security Certifications and Trust Center
Not rated

Not assessed. No named or dated attestation and no trust centre located in this pass.

FDA and Regulatory Status
Not rated

Not a regulated medical device and no clearance is claimed or required for ambient documentation.

AI Governance and Bias Disclosure
B
Vendor Published

Contains the single best language scope disclosure located in this category, held at B only because it stands alone rather than sitting inside a formal governance document. Speke states that it processes audio in 25 or more languages and generates the note IN ENGLISH, then adds explicitly that it CANNOT ACT AS AN INTERPRETER and that a native speaker of the recorded language will need to corroborate note accuracy. That does two things almost no competitor does: it names the limitation, and it assigns the verification duty to a specific person rather than leaving it unowned. Every vendor marketing multilingual capture should be asked to match that sentence. What would move this to A is what Microsoft Dragon Copilot publishes alongside it, a formal transparency document covering accent and dialect performance, unsupported use cases and subgroup considerations. No fairness or subgroup analysis was located here.

Integration and Deployment
EHR and Interoperability Depth
B
Vendor Published

Bidirectional EHR integration was announced in September 2024 with the claim that integration is available for all industry leading and midmarket EHR systems, positioning Speke as EHR agnostic. The breadth is asserted rather than enumerated: no named integrations, certification programmes or partner listings were verified in this pass, so this is graded on the same basis as other asserted breadth claims in this index rather than on demonstrated depth. Bidirectional write back is the meaningful part of the claim and is worth confirming per site.

Deployment Model and Data Residency
Not rated

Not assessed. Cloud based with iOS, Android and desktop clients, but no hosting region, residency or data location detail was located, and the human review layer makes data location a two part question covering both storage and workforce access.

Commercial
Commercial Transparency
C
Vendor Published

No prices published, but more structural transparency than most: three named service tiers, Express, Plus and Pro, tell a buyer that the variable being priced is the depth of human review rather than seats or volume. That is genuinely useful for budgeting a comparison against an automated only scribe, because the cost difference is a known quantity of human labour rather than an opaque margin. Publishing what each tier includes without publishing what any of them costs is halfway to a rate card.

Setting and Specialty Coverage
A
Vendor Published

Among the broadest coverage in this category and unusually well spread across care settings rather than concentrated in outpatient. Roughly 80 specialties spanning ambulatory, acute and urgent care, with genuine emergency department depth inherited from ScribeAmerica's core scribe business, plus veterinary medicine in the parent's service footprint. Audio processing across 25 or more languages, with the honest caveat that output is English. Site specific templates, macros and dot phrases carry over per provider, which is the practical form specialty coverage takes for a clinician switching from a human scribe.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Not published. Three named service tiers: Express, Plus and Pro
Tiered by depth of human scribe review rather than by seat or encounter volume. Enterprise, medical group, emergency department and ambulatory specialty buyers. Not retrieved. Confirm the BAA covers the human review workforce, not only the software. Not published. Vendor Published

No prices are published for any tier. The useful comparison is not against other scribes on price per seat but against the cost of the human scribe this product replaces or supplements, which is the market ScribeAmerica already sells into. One published customer case cites 40,000 US dollars saved through staff reduction. Two questions belong in the same conversation: what each tier actually includes in review depth, and where the reviewing workforce sits, because the human layer is simultaneously the strongest oversight mechanism in this category and its largest PHI exposure surface.

AI Health Index

An independent reference for evaluating AI vendors in healthcare. No vendor pays for inclusion, placement, or rating.

Index Status
Last index update
July 23, 2026
The AI Health Index is an editorial reference, not a regulatory body. Vendor data is verified against published sources and public regulatory filings. Figures labeled “Estimated” have not been confirmed by the vendor. See the Methodology page for evaluation standards and limitations.
© 2026 AI Health Index
3801 N Capital of Texas Hwy, Ste E240 · Austin, TX 78746